NCT00174720 - Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid. | Biotech Hunter

Enrollment

708

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

Asthma

Interventions

DRUG

Ciclesonide (XRP1526)

Trial Locations (11)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, São Paulo

Sanofi-Aventis Administrative Office, Santiago

Sanofi-Aventis Administrative Office, San José

Sanofi-Aventis Administrative Office, Tallinn

Sanofi-Aventis Administrative Office, Netanya

Sanofi-Aventis Administrative Office, Riga

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, Warsaw

Sanofi-Aventis Administrative Office, San Juan

Sanofi-Aventis Administrative Office, Moscow